» Authors » Ying-Yan Ma

Ying-Yan Ma

Explore the profile of Ying-Yan Ma including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 41
Citations 89
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Liu H, Han Y, Jin Q, Wang X, Ma Y, Wang G, et al.
Chin Med J (Engl) . 2018 Jun; 131(12):1412-1419. PMID: 29893357
Background: Very few data have been reported for ST-segment elevation myocardial infarction (STEMI) caused by unprotected left main coronary artery (ULMCA) occlusion, and very little is known about the results...
2.
Zhang L, Li Y, Yang B, Li L, Wang X, Ge M, et al.
Chin Med J (Engl) . 2018 Feb; 131(5):508-515. PMID: 29483383
Background: High platelet reactivity (HPR) during clopidogrel treatment predicts postpercutaneous coronary intervention (PCI) ischemic events strongly and independently. Tongxinluo capsules (TCs) are a traditional Chinese medicine formulation used as antiplatelet...
3.
Xu X, Ma Y, Zou H
J Glaucoma . 2015 Sep; 25(7):e657-62. PMID: 26372156
Purpose: To assess the cost-effectiveness of cataract surgery in advanced glaucoma (AG) patients. Materials And Methods: A total of 93 patients with AG who underwent cataract surgeries were collected prospectively...
4.
Xu X, Sun Q, Ma Y, Zou H
J Glaucoma . 2015 Jun; 25(1):e5-11. PMID: 26066499
Purpose: To demonstrate longitudinal postoperative vision-related quality of life and visual acuity changes after cataract surgery in advanced glaucoma patients. Materials And Methods: In total, 93 patients who underwent cataract...
5.
Zhang J, Li Y, Tao G, Chen Y, Hu T, Cao X, et al.
Chin Med J (Engl) . 2015 Mar; 128(6):784-9. PMID: 25758273
Background: Current randomized trials have demonstrated the effects of short-term rosuvastatin therapy in preventing contrast-induced acute kidney injury (CIAKI). However, the consistency of these effects on patients administered different volumes...
6.
Wang X, Xu K, Li Y, Jing Q, Liu H, Zhao X, et al.
Chin Med J (Engl) . 2015 Mar; 128(6):721-6. PMID: 25758262
Background: Recent studies reported that percutaneous coronary intervention with stent implantation was safe and feasible for the treatment of left main coronary artery (LMCA) disease in select patients. However, it...
7.
Wang G, Han Y, Jing Q, Wang X, Ma Y, Wang B
J Geriatr Cardiol . 2014 Oct; 11(3):218-21. PMID: 25278970
Objective: To evaluate the long-term efficacy of covered stent implantation in the treatment of elderly patients with coronary perforation while undergoing percutaneous coronary intervention (PCI). Methods: From June 2004 to...
8.
Zhang L, Li Y, Jing Q, Wang X, Ma Y, Wang G, et al.
J Interv Cardiol . 2014 Mar; 27(2):119-26. PMID: 24617336
Background: The optimal duration of dual antiplatelet therapy (DAPT) after drug-eluting stent (DES) implantation remains controversial. The primary aim of our study was to evaluate the impact of optimal DAPT...
9.
Han Y, Liu J, Jing Q, Ma Y, Jiang T, Pu K, et al.
Cardiovasc Ther . 2013 May; 31(5):285-90. PMID: 23634911
Objectives: To elucidate the efficacy and safety of pharmacoinvasive therapy by using prourokinase (prouk) in patients with ST-segment elevation myocardial infarction (STEMI). Background: Patients with STEMI often have long percutaneous...
10.
Zhao X, Han Y, Wang S, Wang X, Jing Q, Wang B, et al.
Zhonghua Yi Xue Za Zhi . 2013 Jan; 92(38):2685-8. PMID: 23290106
Objective: To evaluate the efficacy and safety of intra-aortic balloon pump (IABP) counter pulsation in the treatment of ST-segment elevation myocardial infarction (STEMI) with concurrent left main coronary artery (LMCA)...